Patients desire information about health care costs because they are increasingly responsible for these costs. Public Web sites that offer cost information could inform provider-patient discussions of costs at the point of care.
A s patients cope with higher deductibles and copayments, they want to know how much health care costs when making care choices (1) (2) (3) (4) (5) (6) (7) (8) (9) . Despite growing evidence of patients' desire to discuss costs with their doctors (2) (3) (4) (5) 7) and the negative impact of financial barriers on treatment adherence (10, 11) , physicians often do not discuss costs during clinical encounters. Physicians overlook or dismiss opportunities to discuss costs with patients because of time constraints, lack of patient-specific price information, uncertainty about how much procedures and treatments cost, or the belief that no cost-saving solution exists (12) (13) (14) (15) (16) . The growing shared decision-making movement and focus on high-value care (17) creates an imperative to engage patients in discussing preference-sensitive treatments or to reduce inappropriate testing and treatments. Patients' financial concerns are one factor that could influence their treatment choices (18 -20) and should be incorporated into shared decision making.
Policymakers, insurers, and purchasers have supported greater health care price transparency in an effort to help consumers shop for health care services that best meet their needs (21) . Nearly all insurers offer some sort of cost calculator or price transparency tool for their members, and over one half of the U.S. states have passed price transparency laws, with many creating public Web sites to help consumers make more cost-informed choices (22) (23) (24) . These Web sites, including CompareMaine.org, have received high ratings for helpfulness and ease of use (22, 25, 26) , but evidence of their use by consumers or providers to inform cost conversations about treatment choice is mixed (21, 27, 28) . Whereas some studies of price transparency tools offered by private insurers to their members have found an association with choosing lower-cost providers for selected services (laboratory and imaging) (6, 29, 30) , others have found little or no effect on overall outpatient spending, largely because of low awareness and use (31) (32) (33) (34) (35) (36) . Similarly, studies of state-supported cost and quality transparency Web sites have found that only 1% to 2% of consumers use them (6, 37) . Consumers favor word of mouth and physician referrals when making health care choices, with only 3% of consumers consulting online costs before undergoing a procedure (38) . More efforts are needed to raise consumer and provider awareness about cost and quality information and to assess how they might inform treatment choices at the point of care (1, 27, 39, 40) .
This study aimed to evaluate the implementation of tools to facilitate the use of publicly available cost information during clinical visits for low back pain (LBP) and their value to providers and consumers.
METHODS

Study Design and Setting
The study evaluated the implementation of cost conversation tools in 6 primary care practices in 2 health systems by using qualitative interviews with staff and patients and a patient survey to learn 1) how practices integrate cost discussions into clinical workflow; 2) how access to and use of tools and trainings increase provider confidence and perceptions of the frequency of cost discussions with patients; and 3) how cost conversations affected patients' awareness of comparative cost information, care experience, and care choices. The study was approved by the University of Southern Maine Institutional Review Board.
The intervention focused on patients with LBP, one of the most common diagnoses treated in primary care that is estimated to cost more than $26 billion annually (41) . Low back pain is a topic of Choosing Wisely recommendations that was previously piloted in Maine and associated with inappropriate service use, such as imaging, when lower-cost interventions are generally recommended (42) . Although Choosing Wisely recommends discussing costs, providers have reported barriers to discussing costs with patients (43, 44) . Because Maine's public cost Web site includes several recommended nonpharmacologic therapies for LBP (such as physical therapy and osteopathic manipulation) and diagnostic tests (such as radiography and magnetic resonance imaging [MRI]), we aimed to determine how this information informed LBP cost conversations at the point of care.
Data collection included interviews with practice staff and patients, a patient postvisit survey, a clinical provider (for example, physicians or medical assistants) postintervention survey, administrative tracking data collected by the practices, and CompareMaine.org Web-tracking reports.
Intervention
The intervention implemented workflow changes ( Figure 1 of the Supplement, available at Annals.org) to promote the use of provider and patient tools designed to facilitate cost conversations. Practices identified patients with LBP to offer them informational materials (Figures 2 to 5 of the Supplement) at the start of the visit and have clinical providers ask about cost concerns during the visit, using sample scripts (Figures 6 to 8 of the Supplement) and a provider LBP treatment algorithm reference card ( Figure 9 of the Supplement). Patient-focused tools included waiting and examination room posters encouraging them to talk with providers about cost concerns, a LBP treatment card showing average commercial insurer cost ranges for common LBP procedures, and additional CompareMaine.org (45) information. All materials were developed with consumer advisory board input. Practices were provided tablets that could be used to access CompareMaine.org and administer a patient survey.
Training offered to practice staff included 4 webinars, an online training module, and on-site technical assistance. The webinars/trainings focused on the reasons for having cost conversations with patients and ways to facilitate these discussions.
Participant Recruitment
Participating health systems and associated practices were recruited on the basis of a convenience sample. Two health systems that were originally approached declined to participate. Health systems were offered a financial incentive ($9975 each) for infrastructure changes to support practice workflow changes, such as electronic medical record (EMR) reminders to have cost conversations. Practices were offered smaller stipends ($300 per practice) to participate in trainings, facilitate cost conversations using newly developed tools, track patients with LBP and cost conversations, and offer a patient survey at the end of the visit. The intervention involved all staff at participating practices. Practice characteristics are shown in Table 1 .
The patient target population was all adult Englishspeaking patients presenting with LBP during the intervention period (June 2017 to January 2018). There were no other exclusion criteria. Practices tracked the total count of patients with LBP receiving intervention materials and having conversations during the study period and the number of patients accepting or declining the survey.
Survey Methods and Analysis
A postvisit voluntary survey about their experience with the intervention was offered via tablet or paper to all patients with LBP before leaving the office visit (Figure 10 of the Supplement). The survey was developed by project researchers on the basis of the study research questions and adapted from existing instruments, where possible (46 -51) . The survey also asked whether patients would be willing to be contacted for a phone interview to provide more information about their experiences. A gift card raffle was provided as an incentive to complete the survey.
A postintervention voluntary online survey was sent to all 50 clinical providers (for example, physicians and medical assistants) at participating sites about their experience having cost conversations with patients ( Figure 11 of the Supplement), because this was a practice-wide intervention. Respondents may not have interacted with patients with LBP during the intervention period. Survey questions and response options drew from existing questions where possible (52, 53) . Practices were offered the incentive of keeping the tablet if all staff completed the survey.
Surveys were analyzed with descriptive statistics by using SAS software, version 9.4 (SAS Institute).
Interview Methods and Analysis
The research team conducted 11 group interviews with 25 practice staff and 11 health system leaders by phone or on-site at 3 intervals (baseline, midpoint, and postintervention) by using semistructured interview guides ( Figures 12 to 14 of the Supplement) informed by the Consolidated Framework for Implementation Research (54 -56) constructs to evaluate intervention implementation. Practice staff interviewed were based on a convenience sample and may not have interacted with patients with LBP during the intervention period.
Patient interviewees were identified through the patient survey and interviewed by phone using a semistructured interview guide ( Figure 15 of the Supplement). Nonrespondent characteristics are not known as we separated the contact information from the survey responses to maintain anonymity.
Interviews with practices and patients were recorded, transcribed, and entered into NVivo software, version 11 (QSR International) for analysis. Researchers developed an initial (a priori) coding structure based on research and interview questions and reviewed a sample of transcripts to refine them, propose and agree on emergent codes, and develop coding decision rules to refine code definitions. Researchers coded each interview by using this final coding structure, analyzed coding data for themes, and identified thematic exemplar quotes.
Administrative Data and Analysis
Practices tracked the number of patients with LBP who received cost information during the intervention period by using a tablet or paper forms. The type of cost information used (that is, patient-focused tools) was not tracked. The health systems projected the total number of patients with LBP seen in 1 month to esti- 
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RESULTS
Use of Intervention
Engagement of patients with LBP in cost conversations was lower than expected, on the basis of the estimated number of patients with LBP and tracking data provided by all 6 practices. Collectively, practices had estimated more than 380 patients would present with LBP during the intervention period (actual unknown), but only 72 patients with LBP were reported as receiving the intervention (that is, either spoken to about costs or given materials) ( Table 1) . Low uptake of online training among staff and providers may have contributed to the lack of patient engagement in cost conversations. Although at least 1 representative from each system attended the trainings, the online module was viewed by 10 health system and practice staff, of which 8 fully completed the training. Despite low intervention participation rates, use of CompareMaine.org increased for most LBP-related procedures, according to Web site tracking data ( Table 2) .
Interview Findings
On the basis of the 11 group interviews with 25 clinical practice staff and 11 health system leaders and the interviews with 5 patients, we identified several barriers to integrating cost conversations into the LBP clinical workflow using publicly reported information that contributed to low uptake. Of the 47 patients surveyed, 13 agreed to be interviewed, of whom 5 participated (38% response rate).
Limited Health System Leadership and Infrastructure Support
Despite receiving financial incentives for infrastructure support, such as adding a cost question in the EMR, system leaders failed to fully integrate cost conversations into broader quality initiatives or make EMR changes that may have facilitated implementation. Systems reported using funds to support key personnel to oversee the pilot and provide staff support; one system used funds to pay providers for completing the training. The lack of top-down support for the intervention limited provider and practice buy-in relative to other system priorities ( Table 3) .
Difficulties Integrating New Workflow Process for One Condition
Given the unexpectedly low numbers of patients presenting with LBP, practices found it difficult to integrate workflow changes, particularly without EMR flags to ask about costs. Although the intervention targeted all patients with LBP, practices reported having difficulty identifying patients with chronic LBP if it was not the primary reason for the visit. Furthermore, clinical staff were reluctant to introduce cost-of-care conversations with patients with chronic LBP who were already treating or managing their condition ( Table 3 ). The team-based approach also proved challenging; practice team members (such as medical assistants) felt awkward asking about cost concerns before patients discussed treatments with the provider. Some suggested that targeting all patients or all patients with orthopedic concerns, as part of the discussion around the risks and benefits of procedures, may have been preferable.
Providers Believed They Were Already Addressing Cost Concerns When Necessary
Working in rural Federally Qualified Health Centers and critical access hospital practices that serve a large proportion of economically disadvantaged patients, providers believed that they knew which patients had cost concerns (that is, those who were uninsured, selfpaying, or in high-deductible plans) and were discussing costs or referring them to system supports (such as financial counselors) ( Table 3) . Providers did not see a need to discuss costs with patients covered by employerbased insurance, Medicare, or Medicaid. Most providers also felt they had already reduced LBP imaging rates by incorporating evidence-based guidelines into their clinical decision making, and so saw little room to reduce inappropriate imaging costs.
Differing Provider and Patient Perspectives About the Value of Publicly Reported Cost Information
Whereas some providers valued having publicly reported cost information to give to patients, others ex- to keep us engaged and it was a busy time." "There's been a lot of education about back pain and it might be . . . that they're trying their own treatment before they come to us, which is great." "[Sometimes chronic LBP is] not their primary problem, it's not their reason for the visit, but it's on their problem list.
So when they come in they'll bring it up as part of the concern they have for that day." "It was hard for our patients that have had a back pain for a long time that all of a sudden on their 20th visit in 30 years . . . we're starting to talk about cost of care of things they've already had done." "And the one time I [asked a patient about cost concerns], it felt very awkward . . . . I was still a little bit confused about what the point was, so it didn't flow well from my standpoint. It didn't really fit in with how I wanted my visit to go." "It would be really helpful if the [electronic medical records] were set up to 1) show the retail costs of procedures we order, 2) show the patients expected copay after deductible, 3) be able to add the costs with "one click" to the patient summary so its integral to the visit flow."
Health system leadership and infrastructure support Practices and health systems "There is no particular system-wide or systemic push to talk about [costs with patients]." "I feel like this [intervention] didn't really have a home within our existing structure of other projects . . . and it ended up feeling a little bit like the stepchild the whole way through." "Well, to get our system to build in a link [to CompareMaine in the electronic medical record], to tell people to go outside the system, that's going to be a hard sell." "It's theoretically possible [to build a cost concern question into the electronic medical record], but . . . we also need some good data to show it would be worth the work."
Perceived value of and comfort with having cost conversations Practices and health systems "Sometimes I'm not comfortable because I don't know the pricing of everything. Even when our patients have labs, I don't quote any amounts. That's why we have trained financial counselors, because they're trained in that department, but I don't know." "It's hard to bring up the conversation, I'll be honest with you. They're here for their health, not money. 
Helpfulness of publicly available information
Practices and health systems "Because we can show them [CompareMaine] but that doesn't mean that's what they'll be paying, so that's another concern. People want to know, 'What's the cost to me?'" ". . . We don't have as many choices as there are in a lot of places. Insurance companies, insurance precertifications, there are all kinds of things that also limit [where someone can go]. Can they travel? . . . Our population can't shop around as much." "The system is designed to not be transparent so that people can charge too much money . . . so it doesn't really do
[me] much good to tell me how much [a procedure] is going to cost if it doesn't tell you what the patient will end up paying. It's just one more layer of nontransparency." "I wasn't familiar with [CompareMaine] before. I've used it a handful of times but knowing about it is a good resource to give to the patients. I usually don't bring it up in the room to talk to them about it, because it takes that much time for it to load up. But I give them the information." "It's nice to be able to give people something if you're going to refer them to imaging. They can go on the Web site and look at what's the least expensive for them . . . ." "As a critical access hospital, our costs look higher.... And so, when people compare us to someplace else, we sometimes look bad. So we're sort of shooting ourselves in the foot sometimes with some of these conversations. We're aware of that, but we're also very much advocating for our patients." "The most educational thing is just that there's a big diversity in costs . . pressed concerns about its value to rural patients, given limited availability of lower-cost services nearby and, consistent with prior research, the information reflecting average insurer payments rather than the patient's actual costs (16) . In contrast, most patients reported an interest in discussing costs with their doctors and appreciated the information on CompareMaine .org (Table 3) .
Survey Results
Survey results indicated variation in perceived value of discussing costs and sharing publicly reported Using Public Cost Information During LBP Visits cost information between providers and patients. Twenty-five of the 50 clinical staff participated in the provider survey (50% response rate), including 11 clinical providers and 14 medical assistants. Table 1 shows the characteristics of respondents and nonrespondents. Forty-seven of the 72 patients with LBP reported by practices as having received cost information completed the postvisit patient survey (65% response rate). Information about nonrespondents is not known.
Minimal Change in Perceived Frequency of or Provider Comfort With Cost Conversations
Despite provider awareness of practice participation in the intervention (96%), few providers reported a perceived increase in cost conversation frequency. About one third of providers surveyed indicated they never discussed costs with their patients with LBP during the intervention, and only 12% said they gave cost materials and reviewed them with patients ( Table 4) .
For those who addressed costs, providers surveyed were more likely to discuss delaying intervention, using lower-cost alternative therapies, or referring patients to a financial counselor than changing referrals to lowercost locations. Most reported they had a basic understanding of the differences in costs between treatments and that costs can vary by location ( Table 4) .
More Patients Valued Discussing Costs Than Had Cost Conversations With Providers
In general, patients were more interested in discussing costs than practice staff believed. Most patients completing surveys during the intervention agreed that cost discussions with providers were important, but fewer reported having a conversation about LBP treatment costs during their visit. Although providers felt they were discussing costs, one third of patients had put off medical treatment in the past year because of costs, regardless of insurance status. In addition, although practice staff had expressed concern that the patient materials could overwhelm patients, most patients reported the material they received helped them choose how to treat their LBP ( Table 5 ).
Intervention Increased Awareness of CompareMaine.org, but Patients Valued It More Than Providers
Before the intervention, the vast majority of patients and providers were unaware of CompareMaine .org. During the intervention, only 19% of providers viewed or discussed CompareMaine.org with their patients. However, those who did felt it helped show cost variation across facilities, empowering patients in choosing where to seek care. Of the patients and providers who viewed CompareMaine.org during the in- Input from the intervention helped inform changes to CompareMaine.org to improve usability and value to providers and consumers, including reducing minimum reporting thresholds to include more rural providers and increased outreach about the Web site to all primary care practices, hospitals, and other stakeholders (for example, employers and insurers).
DISCUSSION
This study found that a multicomponent intervention with financial incentives to integrate publicly available cost information into clinical discussions using CompareMaine.org, a public Web site of health care cost information, yielded low practice uptake. The generalizability of the study is limited by the small convenience sample, focus on a single clinical condition, reliance on voluntary self-reported provider and patient data, and lack of information about nonrespondents. However, the study offers some lessons that may be instructive for clinicians, health systems, policymakers, and payers hoping to get cost information to consumers at the point of care when it is likely to be most valuable.
We found that patients with LBP were more interested than providers were in discussing costs during clinical encounters. Our findings suggest that clinicians may be missing opportunities to discuss costs with patients, because of assumptions about which patients have cost concerns and what information patients want. Many clinicians believed that fully insured patients did not care about costs. They also questioned the value to patients of public cost Web sites on the basis of issues that patients did not indicate. To address this bias, future initiatives should normalize cost conversations, initiating them and sharing cost resources with all patients, regardless of insurance status or condition.
Cost variation discussions fall outside providers' usual scope of practice expertise, comfort, knowledge, and professional expectations. Providers were more comfortable discussing cost avoidance strategies with patients, such as postponing imaging or using self-care or alternative therapies, than cost variation between referral locations available on public cost Web sites. Provider reluctance to discuss costs with patients and refer to lower-cost settings may also be related to institutional expectations of within-system referrals, particularly in hospital-based practices. Helping consumers "shop" for lower-cost settings is unlikely to be embraced by practices unless system leadership strongly supports it and aligns having cost conversations with other quality improvement and institutional priorities.
As federal and state policymakers consider broadening transparency requirements (57-61), they need to invest in greater public and provider training on the value of these resources and their use during clinical encounters. Promoting cost transparency in rural areas may be more difficult, given the limited ability to "shop" for health services, additional patient costs (such as travel and lost worktime) to access them, and the higher cost of providing services in rural areas. The MRI services offered by the critical access hospital participating in this intervention were among the highest cost in their area. Practice and system leaders acknowledged highlighting these cost variations could affect the viability of their health care organization, further limiting local access. Policymakers may seek to engage other health care stakeholders, such as employers, health plans, and consumer advocacy organizations, in educating consumers about cost and quality transparency tools. Simply mandating price transparency does not guarantee patient and provider use of this information. These efforts should be coupled with guidance about how this cost information should be used at the point of clinical decision making. 
